home / stock / dtc:cc / dtc:cc news

DTC:CC News and Press, Defence Therapeutics Inc. Class A From 05/14/24

Stock Information
Company Name: Defence Therapeutics Inc. Class A
Stock Symbol: DTC:CC
Market: CNQC
Website: defencetherapeutics.com
Menu
DTC:CC DTC:CC Quote DTC:CC Short DTC:CC News DTC:CC Articles DTC:CC Message Board
Get DTC:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC:CC - Defence Therapeutics Strengthens and Expands Global Patent Protection on Key Technologies

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
DTC:CC - Pancreatic Cancer: Successful Trial Against Pancreatic Cancer with Defence Therapeutics' ARM-002 Anti-Cancer Vaccine

Vancouver, British Columbia--(Newsfile Corp. - May 1, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce...

DTC:CC - Defence's AccuTOX Anti-Cancer ARM-002 Vaccine Exhibits Potent Antigen Presentation

Vancouver, British Columbia--(Newsfile Corp. - April 23, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...

DTC:CC - Canadian Companies Moving the Markets, Evening edition
Mon, Apr 22, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada Reunion Gold Corporation (RGD) rose 20.0% to $0.6 on volume of 83,292,382 shares Enbridge Inc. (ENB) rose 1.0% to $48.43 on volume of 21,579,458 shares Kinross Gold Corporation (K) fell 4.5% to $8.89 on volume of 17,117,090 shares TC Energy Co...
DTC:CC - Defence Therapeutics Signs with German Based FMS Consult GmbH for Financing Strategy to Support Defence Pipeline Growth

Vancouver, British Columbia--(Newsfile Corp. - April 17, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...

DTC:CC - Canadian Companies Moving the Markets, Evening edition
Tue, Apr 09, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada Anfield Energy Inc. (AEC) rose 10.0% to $0.11 on volume of 17,730,503 shares Toronto-Dominion Bank (The) (TD) rose 0.4% to $80.18 on volume of 15,083,256 shares Lundin Mining Corporation (LUN) rose 2.8% to $16.44 on volume of 12,337,076 shares ...

DTC:CC - Canadian Companies Moving the Markets, Evening edition
Mon, Apr 08, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada i-80 Gold Corp. (IAU) fell 11.9% to $1.63 on volume of 16,961,431 shares Toronto-Dominion Bank (The) (TD) fell 1.0% to $79.86 on volume of 16,589,840 shares Baytex Energy Corp. (BTE) fell 2.9% to $5.3 on volume of 12,801,590 shares Cenovus Ene...
DTC:CC - Defence Therapeutics Announces Warrant Terms Amendment

Vancouver, British Columbia--(Newsfile Corp. - April 5, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces an amendment to the terms of 1,49...

DTC:CC - Defence Therapeutics: Developing Next Generation Therapies to Combat Cancer with Propietary ACCUM(TM) Technology

2024-03-27 17:08:02 ET Stocks to Invest in: Biotech Cancer treatment along with other infectious diseases need clinical solutions and this company may have one. BTV interviews Defense Therapeutics to learn about their proprietary ACCUM™ technology and its proven ability to ...

DTC:CC - Defence's Successful Results on Its AccuTOX Anti-Cancer ARM Vaccine Creates a Potent Second-Generation Anti-Cancer ARM-002 Vaccine

Vancouver, British Columbia--(Newsfile Corp. - March 26, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biotechnology company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce t...
Previous 10 Next 10